High-Throughput Nucleotide Sequencing: Clinical Trials

2 trials of High-Throughput Nucleotide Sequencing, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

1 completed, 1 recruiting. 2 Phase 3, 1 Phase 2.

By phase and status

PhaseTrialsStatus
Phase 32Completed 1, Recruiting 1
Phase 21Recruiting 1

Follow High-Throughput Nucleotide Sequencing: new trials by email Literature Review of High-Throughput Nucleotide Sequencing trials Research Report on High-Throughput Nucleotide Sequencing

Trials (filtered) newest first · largest first

All 2 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Exploring the Impact of Genetic Variations on The Clinical Efficacy of Nalbuphine in Postoperative Pain Management
Nalbuphine Injection, Next Generation Sequencing, whole exome sequencing - Cholecystectomy, Hernia, Abdominal
Phase 2 / Phase 3RecruitingDr. Asma Abdus Salam2632025-09-012026-04-15
Molecular Profiling of Advanced Soft-tissue Sarcomas
Nilotinib, Ceritinib, Capmatinib - Soft Tissue Sarcoma
Phase 3CompletedInstitut National de la Santé Et de la Recherche Médicale, France6032019-10-192026-04-29

Conditions studied

Hernia, Abdominal (1)  ·  Neoplasm Metastasis (1)  ·  Pain, Postoperative (1)  ·  Sarcoma (1)

Sponsors

Dr. Asma Abdus Salam (1)  ·  Institut National de la Santé Et de la Recherche Médicale, France (1)

Countries

France (1)  ·  Pakistan (1)

Top investigators

Antoine Italiano (1)  ·  Talat Mirza, FCPS PhD (1)

Results publications

PMID 28409480, PMID 32713836, PMID 34740331

NIH funding

2017 (1)